Purna Pharmaceuticals NV
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Purna Pharmaceuticals NV - overview
Established
1986
Location
-, -, Belgium
Primary Industry
Pharmaceuticals
About
Based in PUURS, Belgium, and founded in 1986, Purna Pharmaceuticals NV operates as a producer of pharmaceutical products to meet GxP standards as per specific client's requirements. In December 2003, Purna Pharmaceuticals NV raised growth funding from Creafund. Purna Pharmaceuticals NV provides a variety of development services, such as pharmaceuticals, human and veterinary medical devices, and cosmetics. The company offers a variety of development laboratories, such as a GLP-compliant analytical laboratory that is for analytical development, formulation development, the IMP clinical phase, and API’s.
In addition, the firm provides manufacturing of a wide range of products including liquid, semi-solid, and powder. Purna Pharmaceuticals generates revenue through contract development and manufacturing of liquid, semi‑solid, and powder pharmaceutical products, including formulation development, GMP manufacturing, and services for global pharma, biotech, NGO, and public‑sector clients. In February 2026, Ampersand acquired Purna Pharmaceuticals NV from Creafund. The acquisition enables Pharmaceuticals NV to enhance its innovation, quality, and capacity while expanding global pharmaceutical manufacturing services.
Primary Industry
Pharmaceuticals
Sub Industries
Medical Supplies, Pharmaceutical Research & Development, Medical Software
Website
www.purna.be
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Purna Pharmaceuticals NV - timeline of key events
Purna Pharmaceuticals NV - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 24,415,276 | 25,356,624 | 26,959,546 | 30,296,820 | 28,159,264 | 30,511,948 | 36,904,098 | 43,078,957 | 33,803,083 | - | - | - |
| % Revenue Growth (YoY) | - | 3.9% | 6.3% | 12.4% | (7.1%) | 8.4% | 20.9% | 16.7% | (21.5%) | - | - | - |
| EBITDA (USD) | 2,617,111 | 2,309,963 | 2,465,712 | 2,926,764 | 1,869,170 | 1,119,365 | 2,173,244 | 4,456,704 | 2,314,615 | - | - | - |
| Operating Income (USD) | 1,133,966 | 1,057,636 | 1,226,553 | 1,691,588 | 30,126 | (942,344) | 196,673 | 2,405,470 | (199,154) | - | - | - |
| Operating Margin | 4.6% | 4.2% | 4.5% | 5.6% | 0.1% | (3.1%) | 0.5% | 5.6% | (0.6%) | - | - | - |
| % EBITDA Margin | 10.7% | 9.1% | 9.1% | 9.7% | 6.6% | 3.7% | 5.9% | 10.3% | 6.8% | - | - | - |
| NET Income (USD) | 310,693 | 220,048 | 284,695 | 995,055 | (378,244) | (1,464,518) | 32,546 | 1,874,485 | (575,563) | - | - | - |
| % Net Margin | 1.3% | 0.9% | 1.1% | 3.3% | (1.3%) | (4.8%) | 0.1% | 4.4% | (1.7%) | - | - | - |
Purna Pharmaceuticals NV - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.